Literature DB >> 10971345

Hypereosinophilic syndrome presenting as cutaneous necrotizing eosinophilic vasculitis and Raynaud's phenomenon complicated by digital gangrene.

K A Jang1, Y S Lim, J H Choi, K J Sung, K C Moon, J K Koh.   

Abstract

Cutaneous necrotizing eosinophilic vasculitis is a recently identified type of vasculitis that is characterized by an eosinophil-predominant necrotizing vasculitis affecting small dermal vessels. Clinically, it presents with pruritic erythematous and purpuric papules and plaques, peripheral eosinophilia and a good response to systemic steroid therapy. This vasculitis can be idiopathic or associated with connective tissue diseases. Although the pathogenic roles of eosinophil-derived granule proteins and interleukins have been documented in diseases associated with eosinophilia, a role of CD40 (a glycoprotein of the tumour necrosis factor receptor superfamily) has rarely been described. We describe two patients with idiopathic hypereosinophilic syndrome (HES) presenting with multiple erythematous patches and plaques on the lower extremities and Raynaud's phenomenon. They satisfied the criteria for the diagnosis of HES by clinical and laboratory investigations. Histopathology of the cutaneous lesions revealed prominent eosinophilic infiltration with local fibrinoid change in vessel walls in the dermis and subcutis. Immunohistochemical detection of CD3, CD4, CD8 and CD40 was performed. Infiltrating eosinophils were strongly stained by anti-CD40 monoclonal antibody. One patient improved with prednisolone, pentoxifylline and nifedipine, without recurrence. The other patient initially improved with steroids, but after self-withdrawal of steroid developed digital ischaemia that evolved to severe necrosis and required amputation. Cutaneous necrotizing eosinophilic vasculitis, Raynaud's phenomenon and digital gangrene may develop as cutaneous manifestations of HES. CD40 may play a part in the pathogenesis of eosinophilic vasculitis in HES.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971345     DOI: 10.1111/j.1365-2133.2000.03726.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  [Leucocytoclastic eosinophilic vasculitis with Löffler syndrome].

Authors:  P-G Sator; R Feldmann; T Wanke; F Gschnait; F Breier
Journal:  Hautarzt       Date:  2007-05       Impact factor: 0.751

2.  Eosinophilic vasculitis: time for recognition of a new entity?

Authors:  Arjun Datt Law; Subhash Varma; Neelam Varma; Alka Khadwal; Gaurav Prakash; Vikas Suri; Savita Kumari; Pankaj Malhotra
Journal:  Indian J Hematol Blood Transfus       Date:  2014-04-16       Impact factor: 0.900

Review 3.  Clinical overview of cutaneous features in hypereosinophilic syndrome.

Authors:  Sabine Gisela Plötz; Bettina Hüttig; Birgit Aigner; Christian Merkel; Knut Brockow; Cezmi Akdis; Ulf Darsow; Johannes Ring
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

4.  Development of Eosinophilic Temporal Arteritis and Digital Ischemia in a Patient with Hypereosinophilic Syndrome.

Authors:  Kayo Ishii; Takahiro Mizuuchi; Yusuke Yamamoto; Hiroaki Mori; Mayu Tago; Eri Kato; Haeru Hayashi; Koichiro Tahara; Tetsuji Sawada
Journal:  Intern Med       Date:  2020-02-26       Impact factor: 1.271

5.  Polyarteritis Nodosa with Marked Eosinophilia, Associated with Severe Gastrointestinal Tract Involvement and Recurrent Venous Thrombosis.

Authors:  Hiroshi Oiwa; Kohei Taniguchi; Natsuki Miyoshi; Keiko Sasaki; Kouichi Ichimura; Tetsushi Kubota; Daisuke Sato
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

6.  Idiopathic hypereosinophilic syndrome with cutaneous necrosis and multiorgan embolism.

Authors:  Huan Wang; Hua Zhong; WenChieh Chen; Haixing Cheng; Fei Hao; Zhiqiang Song
Journal:  JAAD Case Rep       Date:  2019-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.